- The American Cancer Society estimates
that in 2005, about 10,370 cases of invasive cervical cancer will be diagnosed
in the United States.
- Around 3,710 women will die from
cervical cancer in the United States during 2005.
- Some researchers estimate that
non-invasive cervical cancer (carcinoma in situ) is about four times more
common than invasive cervical cancer.
- Cervical cancer is caused by
human papilloma virus (HPV), a sexually transmitted infection.
- In the US, up to 70% of sexually
active women will become infected with human papillomavirus (HPV) during
- A college female has a 60% likelihood
of becoming infected with HPV during her 4 years in college.†
- Worldwide, HPV causes approximately
470,000 cases of cervical cancer annually. (Approximately 31,000 women die
from cervical cancer per year in Europe.)
- Cervical cancer was once one
of the most common causes of cancer death for American women. Since the
introduction of the Pap smear, the number of cervical cancer deaths in the
United States has dropped by 74%.
- The death rate from cervical
cancer continues to decline by about 2% a year.††
- Half of women diagnosed with
cervical cancer in the US are between the ages of 35 and 55. It rarely occurs
in women younger than 20.
- Although cervical cancer does
affect young women, many older women do not realize that the risk of developing
cervical cancer is still present as they age. Slightly over 20% of women
with cervical cancer are diagnosed in the US when they are over 65. It is
important for older women to continue having regular Pap tests at least
until age 70, and possibly longer.
- The 5-year relative survival
rate for invasive cervical cancer that is caught at its earliest stage is
nearly 100%. If it is a little more advanced but hasn't spread to the lymph
nodes or anywhere else, the survival rate drops to 92%. The overall (all
stages combined) 5-year survival rate for cervical cancer is about 73% in
the United States.
- Two different vaccines for HPV
are currently in development: Cervarex (Glaxo Smith Kline) and Gardasil
(Merck & Company). Gardasil is expected to be the first available in
the US in 2006.
- A test for HPV is available in conjunction with a Pap test:† DNA with Papô
(Digene).† This is recommended for women over age 30 who have been sexually
Created: 4/16/2005  - Donnica Moore, M.D.
All the content contained herein is copyrighted pursuant to federal law. Duplication or use without
the express written permission of DrDonnica.com subjects the violator to both civil & criminal penalties.
Copyright © 2006 DrDonnica.com. All rights reserved.
| Today on DrDonnica.com
| Meet Dr. Donnica
| TV Appearances
| Clinical Trials
Diseases & Conditions
| Celebrity Speak Out
| Guest Experts
| Women's Health Champions
| Womenís Health Resources
| Books & Tapes
| Site Certification
| Advanced Search
| Whatís New?
| Press Room
| Contact Us